These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 29187469)

  • 41. Image-guided interstitial high-dose-rate brachytherapy for locally recurrent uterine cervical cancer: A single-institution study.
    Umezawa R; Murakami N; Nakamura S; Wakita A; Okamoto H; Tsuchida K; Kashihara T; Kobayashi K; Harada K; Takahashi K; Inaba K; Ito Y; Igaki H; Masui K; Yoshida K; Jingu K; Tselis N; Itami J
    Brachytherapy; 2018; 17(2):368-376. PubMed ID: 29275869
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preliminary results of magnetic resonance imaging-aided high-dose-rate interstitial brachytherapy for recurrent uterine carcinoma after curative surgery.
    Kotsuma T; Yoshida K; Yamazaki H; Takenaka T; Konishi K; Isohashi F; Koizumi M; Tanaka E; Yoshioka Y
    J Radiat Res; 2011; 52(3):329-34. PubMed ID: 21467737
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Template-based high-dose-rate interstitial brachytherapy in gynecologic cancers: a single institutional experience.
    Mahantshetty U; Shrivastava S; Kalyani N; Banerjee S; Engineer R; Chopra S
    Brachytherapy; 2014; 13(4):337-42. PubMed ID: 24176863
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High dose-rate versus low dose-rate brachytherapy for lip cancer.
    Ghadjar P; Bojaxhiu B; Simcock M; Terribilini D; Isaak B; Gut P; Wolfensberger P; Brömme JO; Geretschläger A; Behrensmeier F; Pica A; Aebersold DM
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1205-12. PubMed ID: 22099044
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Time Course and Accumulated Risk of Severe Urinary Adverse Events After High- Versus Low-Dose-Rate Prostate Brachytherapy With or Without External Beam Radiation Therapy.
    Tward JD; Jarosek S; Chu H; Thorpe C; Shrieve DC; Elliott S
    Int J Radiat Oncol Biol Phys; 2016 Aug; 95(5):1443-1453. PubMed ID: 27325475
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Current controversies in high-dose-rate versus low-dose-rate brachytherapy for cervical cancer.
    Stewart AJ; Viswanathan AN
    Cancer; 2006 Sep; 107(5):908-15. PubMed ID: 16874815
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prospective study of HDR (192Ir) versus MDR (137Cs) intracavitary brachytherapy for carcinoma of the uterine cervix.
    Tanaka E; Oh RJ; Yamada Y; Shiomi H; Nakamura S; Shimamoto S; Teshima T; Inoue T; Inoue T
    Brachytherapy; 2003; 2(2):85-90. PubMed ID: 15062145
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical results of combined treatment conformal high-dose-rate iridium-192 brachytherapy and external beam radiotherapy using staging lymphadenectomy for localized prostate cancer.
    Hiratsuka J; Jo Y; Yoshida K; Nagase N; Fujisawa M; Imajo Y
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):684-90. PubMed ID: 15183471
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Early results of pulsed-dose-rate interstitial brachytherapy for head and neck malignancies after limited surgery.
    Strnad V; Lotter M; Grabenbauer G; Sauer R
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):27-30. PubMed ID: 10656368
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Use of conformal high-dose rate brachytherapy for management of patients with prostate cancer: optimizing dose escalation.
    Vicini FA; Kestin LL; Martinez AA
    Tech Urol; 2000 Jun; 6(2):135-45. PubMed ID: 10798815
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reirradiation using high-dose-rate interstitial brachytherapy for locally recurrent cervical cancer: a single institutional experience.
    Mabuchi S; Takahashi R; Isohashi F; Yokoi T; Okazawa M; Sasano T; Maruoka S; Anzai M; Yoshioka Y; Ogawa K; Kimura T
    Int J Gynecol Cancer; 2014 Jan; 24(1):141-8. PubMed ID: 24362719
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of efficacy and safety of low-dose-rate vs. high-dose-rate intraluminal brachytherapy boost in patients with superficial esophageal cancer.
    Tamaki T; Ishikawa H; Takahashi T; Tamaki Y; Kitamoto Y; Okamoto M; Noda SE; Katoh H; Shirai K; Sakurai H; Nakano T
    Brachytherapy; 2012; 11(2):130-6. PubMed ID: 21700506
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phase II trial of brachytherapy alone after lumpectomy for select breast cancer: toxicity analysis of RTOG 95-17.
    Kuske RR; Winter K; Arthur DW; Bolton J; Rabinovitch R; White J; Hanson W; Wilenzick RM
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):45-51. PubMed ID: 16503383
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Seven fractions of twice daily high dose-rate brachytherapy for node-negative carcinoma of the mobile tongue results in loss of therapeutic ratio.
    Lau HY; Hay JH; Flores AD; Threlfall WJ
    Radiother Oncol; 1996 Apr; 39(1):15-8. PubMed ID: 8735489
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
    Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
    Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Brachytherapy improves biochemical failure-free survival in low- and intermediate-risk prostate cancer compared with conventionally fractionated external beam radiation therapy: a propensity score matched analysis.
    Smith GD; Pickles T; Crook J; Martin AG; Vigneault E; Cury FL; Morris J; Catton C; Lukka H; Warner A; Yang Y; Rodrigues G
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):505-16. PubMed ID: 25596107
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Outpatient-based high-dose-rate interstitial brachytherapy for gynecologic malignancies.
    Dyk PT; Richardson S; Badiyan SN; Schwarz JK; Esthappan J; Garcia-Ramirez JL; Grigsby PW
    Brachytherapy; 2015; 14(2):231-7. PubMed ID: 25556865
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interstitial high-dose-rate brachytherapy in the treatment of base of tongue carcinoma.
    Takácsi-Nagy Z; Polgár C; Oberna F; Somogyi A; Major T; Remenár E; Fodor J; Kásler M; Németh G
    Strahlenther Onkol; 2004 Dec; 180(12):768-75. PubMed ID: 15592696
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Salvage high-dose-rate interstitial brachytherapy for locally recurrent rectal cancer: long-term follow-up results.
    Morimoto M; Isohashi F; Yoshioka Y; Suzuki O; Seo Y; Ogata T; Akino Y; Koizumi M; Ogawa K
    Int J Clin Oncol; 2014 Apr; 19(2):312-8. PubMed ID: 23728882
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vaginal Dose Is Associated With Toxicity in Image Guided Tandem Ring or Ovoid-Based Brachytherapy.
    Susko M; Craciunescu O; Meltsner S; Yang Y; Steffey B; Cai J; Chino J
    Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1099-105. PubMed ID: 26883564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.